Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3137 Neoplasms 2472 Carcinoma, Non-Small-Cell Lung 1886 Prostatic Neoplasms 1635 Colorectal Neoplasms 1435 Lung Neoplasms 1308 Multiple Myeloma 939 Neoplasm Metastasis 928 Leukemia, Myeloid, Acute 884 Pancreatic Neoplasms 856 Ovarian Neoplasms 810 Melanoma 791 Carcinoma, Hepatocellular 742 Stomach Neoplasms 648 Brain Neoplasms 641 Recurrence 640 Squamous Cell Carcinoma of Head and Neck 639 Head and Neck Neoplasms 612 Glioblastoma 573 Lymphoma 550 Uterine Cervical Neoplasms 545 Triple Negative Breast Neoplasms 513 Precursor Cell Lymphoblastic Leukemia-Lymphoma 509 Carcinoma, Renal Cell 504 Hematologic Neoplasms 466 Endometrial Neoplasms 466 Urinary Bladder Neoplasms 462 Colonic Neoplasms 446 Lymphoma, Non-Hodgkin 439 Sarcoma 436

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Herpes Zoster × 1 year × Clear all

NCT06070961 2025-06-29

FIL_FollVax22

Fondazione Italiana Linfomi - ETS

COVID-19, Diphtheria, Herpes Zoster, Lymphoma, Lymphoma, Follicular, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡